Download Increaseing Access to and Delivery of HPV Vaccines

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
HPV VACCINATION
Dr Frida Mghamba
2nd East Africa WE CAN
Summit
11th September 2014
Outline
• Introduction
• Comprehensive approach for cervical cancer
prevention and control
• HPV vaccination Demonstration project
• Lesson learned in HPV vaccination
• Role of GAVI and WHO
Introduction
• Cervical cancer is the abnormal uncontrolled
growth of cells in the cervix.
• The cells of the cervix change in a way that
leads to abnormal growth and invasion of other
tissues or organs of the body.
•
Nearly all cervical cancers are caused by HPV
infection.
• There are more than 40 HPV types that can
infect the genital areas of males and females
• The HPV types 16 and 18 account for about
70% of all HPV cervical cancers worldwide
Comprehensive Approach to cervical
cancer prevention and control
• Primary prevention
– Education: delay age of first sexual
intercourse, use condoms, limit number of
partners, avoid tobacco use
– HPV vaccines
• Secondary prevention: early
detection
– Screening: Identify and treat precancerous
lesions before they progress to cervical
cancer
– Early diagnosis: Identify and treat early
cancer while chance of cure is still good
(reduces cervical cancer mortality)
• Tertiary prevention: treatment and
palliative care
HPV vaccination
• HPV vaccination is the primary preventive method for
cervical cancers caused by HPV infection.
• It prevents women from acquiring HPV infection in the
first instance, so there is no risk of an infection
progressing to cervical cancer later in life.
• The vaccine is recommended by WHO for ages 9-13
years.
• The HPV vaccine is safe , very effective and provides
complete immunity after two doses six months apart.
•
HPV vaccination demonstration
project
• HPV demonstration project aims to demonstrate how the HPV
vaccine targeting girls aged 9-13 years can be delivered in routine
setting and its implication on coverage feasibility, acceptability and
cost.
•
Target age group for the HPV vaccination is school-going girls,
school-based vaccination is one of the vaccination strategies
adopted to achieve the best coverage rates.
• Data from the MOEVT show that girls with 9-13 years 95% are in
grade IV therefore this programme target all girls in class IV with
age 9 and above.
• The girls out of school due to various reasons was vaccinated with
age of 9years..
RESULT OF HPV VACCINATION
• 1st round of HPV vaccination was conducted
on 5th to 9th May this year in Kilimanjaro
region
• Total number of girls vaccinated in school was
17,222 out of 18,316 (94.0%)
• The girls vaccinated out of schools were 416
out of 597(69.70%).
• Overall coverage was 93%
HPV VACCINATION COVERAGE
CHALLENGES
• Misconception among
parents/guardian
• Refusal because of
religious belief in three
religious schools
• Fund for operational for the
2nd year
LESSON LEARNT
• Community health worker can be used as platform for reaching hard
to reach and out of school
• Through micro planning resulted into good vaccination coverage,
better resources utilization and avoidance of duplication
• Operational plan correctly resulted into appropriate proper
distribution of vaccine and supplies
• Delivering of vaccine in school is cheap and cost effective strategies
• Targeted girls who were already vaccinated can be used as
ingredient for change and increase acceptance among girls and
community
ROLE OF GAVI AND WHO
GAVI
• To provide financial support
• To supply HPV vaccines
WHO
• To provide technique support in
– Training
– Supportive supervision
– Monitoring and evaluation
Thank you